NDC 52959-892

Cymbalta

Duloxetine Hydrochloride

Cymbalta is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Duloxetine Hydrochloride.

Product ID52959-892_908e6b8e-0116-4024-bcb4-4f27938301a6
NDC52959-892
Product TypeHuman Prescription Drug
Proprietary NameCymbalta
Generic NameDuloxetine Hydrochloride
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2010-01-15
Marketing CategoryNDA / NDA
Application NumberNDA021427
Labeler NameH.J. Harkins Company, Inc.
Substance NameDULOXETINE HYDROCHLORIDE
Active Ingredient Strength60 mg/1
Pharm ClassesNorepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 52959-892-30

30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (52959-892-30)
Marketing Start Date2010-01-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52959-892-30 [52959089230]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-01-15
Inactivation Date2020-01-31

NDC 52959-892-60 [52959089260]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-01-15
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DULOXETINE HYDROCHLORIDE60 mg/1

OpenFDA Data

SPL SET ID:059d730b-4294-47e1-8399-4cb8c468cee8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 615186
  • 596934

    • Pharmacological Class

    • Norepinephrine Uptake Inhibitors [MoA]
    • Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    • Serotonin Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "Cymbalta" or generic name "Duloxetine Hydrochloride"

    NDCBrand NameGeneric Name
    0002-3235CymbaltaDuloxetine hydrochloride
    0002-3240CymbaltaDuloxetine hydrochloride
    0002-3270CymbaltaDuloxetine hydrochloride
    21695-145CymbaltaDuloxetine hydrochloride
    21695-146CymbaltaDuloxetine hydrochloride
    68151-4734CymbaltaCymbalta
    68151-4679CymbaltaCymbalta
    21695-657CymbaltaCymbalta
    35356-843CymbaltaCymbalta
    43353-303CymbaltaCymbalta
    49999-618CymbaltaCymbalta
    52959-892CymbaltaCymbalta
    55289-028CymbaltaCymbalta
    55289-036CymbaltaCymbalta
    70518-2100CymbaltaCymbalta
    70518-2099CymbaltaCymbalta
    80425-0086CymbaltaCymbalta
    80425-0119CymbaltaCymbalta
    0904-7043DuloxetineDuloxetine Hydrochloride
    0904-7044DuloxetineDuloxetine Hydrochloride
    0904-7045DuloxetineDuloxetine Hydrochloride
    0615-8034Duloxetine HydrochlorideDuloxetine Hydrochloride
    0615-8035Duloxetine HydrochlorideDuloxetine Hydrochloride
    0904-6452Duloxetine HydrochlorideDuloxetine Hydrochloride
    0904-6453Duloxetine HydrochlorideDuloxetine Hydrochloride
    0904-6454Duloxetine HydrochlorideDuloxetine Hydrochloride

    Trademark Results [Cymbalta]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CYMBALTA
    CYMBALTA
    78859969 3194152 Live/Registered
    Eli Lilly and Company
    2006-04-12
    CYMBALTA
    CYMBALTA
    76535580 not registered Dead/Abandoned
    Eli Lilly and Company
    2003-07-25
    CYMBALTA
    CYMBALTA
    75867543 2802665 Live/Registered
    Eli Lilly and Company
    1999-12-09
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.